Ï㽶ÊÓƵ

Home / News

Multiple ALS projects at The Neuro awarded funding

Program brings together multidisciplinary teams with expertise in various areas of neurodegenerative disease

Ìý

Researchers at The Neuro (Montreal Neurological Institute-Hospital) make up a large part of eight projects funded by ALS Canada and the Brain Canada Foundation as part of their 2020 Discovery Grant Program, which brings together multidisciplinary research teams with expertise in various areas of ALS and neurodegenerative diseases to investigate critical areas of disease processes and clinical care.

Classified as: Neuro, ALS, amyotrophic lateral sclerosis, Angela Genge, Gary Armstrong, Eric Shoubridge, Sali Farhan, Rami Massie, ALS Canada, Brain Canada, Montreal Neurological Institute
Category:
Published on: 15 Feb 2021

Improving research with more effective antibodies

Scientists demonstrate flaws in protein detection tools, and outline a solution

A new study points to the need for better antibody validation, and outlines a process that other labs can use to make sure the antibodies they work with function properly.

Antibodies are used in laboratories and clinics to study proteins, which are the biomolecules that translate information from an organism’s genes into the structure, function, and regulation of its tissues and organs. Genetic mutations can cause protein imbalances or malfunctions, leading to human disease.

Classified as: ALS, Peter McPherson, antibodies, proteins, genetics, reproducibility, amyotrophic lateral sclerosis, genes
Category:
Published on: 15 Oct 2019

The MNI forms promising Open Science partnership with Takeda

Industry and academia team up for the benefit of people suffering from ALS

A unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.

The partnership between The Montreal Neurological Institute and Hospital (MNI) and Takeda Pharmaceutical Company Limited (Takeda) will allow compounds developed by Takeda scientists to be tested on cell lines produced at the MNI.

Classified as: Takeda, stem cells, ALS, hiPSCs, amyotrophic lateral sclerosis, open science, C-BIGR, Thomas Durcan, Edward Fon, Guy Rouleau
Category:
Published on: 4 Dec 2017

The Neuro to create world’s first ALS Phase 1 clinical trial unit

The Tenaquip Foundation donation will allow for faster drug development, better care for ALS patients

Ìý

A generous donation by The Tenaquip Foundation will improve the quality of care available to ALS patients at The Neuro, and increase the rate at which researchers can evaluate new ALS drugs.

Classified as: ALS, amyotrophic lateral sclerosis, Reed Family, Tenaquip Foundation, clinical trial unit, drug development, Angela Genge, Guy Rouleau
Category:
Published on: 3 Jul 2017

ALS – Fostering awareness of a devastating disease

ALS takes away the patient’s motor functions one at a time, and the progress of finding effective drugs to counter its insidious effects has been slow. June is ALS Month, a good time to update the public on the latest developments in ALS research taking place at The Neuro.

The Montreal Neurological Institute and Hospital (The Neuro) is recognized as a leading Canadian centre for research into amyotrophic lateral sclerosis (ALS) as well as for its care of ALS patients.

Classified as: ALS, amyotrophic lateral sclerosis, Hiroshi Tsuda, Eric Shoubridge, Guy Rouleau, Peter McPherson, Rami Massie, Heidi McBride, Angela Genge, Heather Durham, Gary Armstrong, zebrafish, C9ORF72, Patrick Dion, Edward Fon, Stefano Stifani
Category:
Published on: 2 Jun 2017

ALS Awareness Month – June 2016

The Neuro is recognized as a major Canadian center for ALS research and patient care. During June, designated ALS Month, The Neuro redoubles its efforts to inform the public and the media about amyotrophic lateral sclerosis (ALS), and urges all to help support ALS research.

Classified as: ALS, amyotrophic lateral sclerosis, Neurology, neuroscience, Angela Genge, Dr. Angela Genge, Rami Massie, Guy Rouleau, Bernard Brais, Heather Durham, Heidi McBride, Peter McPherson, Eric Shoubridge, Stefano Stifani, Hiroshi Tsuda
Category:
Published on: 13 Jun 2016

ALS Awareness Month – June

As a major Canadian centre for amyotrophic lateral sclerosis (ALS) research and treatment, the Montreal Neurological Institute and Hospital - The Neuro, invites the public and the media to learn more about the disease and current research and treatments, to donate money for ALS research and to wear the national emblem of ALS in Canada, the blue cornflower, during ALS Awareness Month in June.

Classified as: neuroscience, Neurology, ALS, amyotrophic lateral sclerosis, Montreal Neurological Institute and Hospital, mcgill faculty of medicine research, Stefano Stifani, Hiroshi Tsuda, Peter McPherson, Guy Rouleau, Eric Shoubridge, Angela Genge, Rami Massie, Heidi McBride, Bernard Brais, Heather Durham
Category:
Published on: 2 Jun 2015
Back to top